Are you confident that your initiative will succeed? Most pharmaceutical companies we come in contact with are enthusiastically adopting AI for elements of their work – be it in discovery, R&D, clinical trials, regulatory, market access, or sales and marketing. Many pharma executives are aware that AI will disrupt pharma business but they are not sure how to ensure that their business is positively disrupted. In order to succeed, AI initiatives must be planned and executed effectively. Choosing a supplier is only the first step in achieving a successful scalable project. Assuming that a large company will achieve a good solution may not always be the case.